课题基金 / 基金详情

HUMAN MOUSE ANTI GD2 MONOCLONAL ANTIBODY FOR ADVANCED NEUROBLASTOMA

HUMAN MOUSE ANTI GD2 MONOCLONAL ANTIBODY FOR ADVANCED NEUROBLASTOMA
用于晚期神经母细胞瘤的人鼠抗 GD2 单克隆抗体
批准号:
6265147
负责人:
Alice L. Yu
金额:
$1.15万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Alice L. Yu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Earlier work suggested that the efficacy of the mouse monoclonal Mab 14G2a is limited by an antibody response in the treated patients. Thus, a chimeric human-mouse monoclonal has been produced against the GD2 antigens and will be tested in this Phase 1 study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma
Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma
Immune Monitor-- COG Trial of Anti-GD2 in Neuroblastoma
IMMUNE MONITOR FOR COG TRIAL OF ANTI-GD2 IN NEUROBLASTOMA
海外基金